Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $300.0000 (-15.49%) ($140.0000 - $355.0000) on Mon. Feb. 23, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 13.55% (three month average) | RSI | 8 | Latest Price | $300.0000(-15.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -6.775% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.775% (StdDev 13.55%) | Hourly BBV | 0 () | Intraday Trend | -15.5% | | | |
|
Resistance Level | $360.19 | 5 Day Moving Average | $346(-13.29%) | 10 Day Moving Average | $350(-14.29%) | 20 Day Moving Average | $360.19(-16.71%) | To recent high | -50% | To recent low | 42.9% | Market Cap | $5.909b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |